Two-site immunochemiluminometric assay for human alpha 1-fetoprotein.
Open Access
- 1 August 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 29 (8) , 1480-1483
- https://doi.org/10.1093/clinchem/29.8.1480
Abstract
In this two-site immunochemiluminometric assay for human alpha 1-fetoprotein, acridinium ester-labeled monoclonal antibodies are used that have an average incorporation ratio of 0.3 mol of acridinium ester per mole of antibody. The solid-phase antibody consists of sheep anti-alpha 1-fetoprotein IgG covalently coupled to a diazonium derivative of reprecipitated aminoaryl cellulose. The assay involves a 1-h incubation after the simultaneous incubation of labeled and solid-phase antibodies. The subsequent quantification time is 10 s per tube. The assay has a working range of 20 to 246 kilo-int. units/L for CVs less than or equal to 10% and a sensitivity of detection of 1.3 kilo-int. units/L. Experiments with monoclonal antibodies labeled to an average incorporation ratio of 2.8 mol of acridinium ester per mole of antibody suggest that assay sensitivity increases with increased specific activity. alpha 1-Fetoprotein concentrations in the sera of pregnant women at 14-20 weeks of gestation, as measured by the present assay, agreed with the results of a conventional radioimmunoassay.This publication has 4 references indexed in Scilit:
- Acridinium esters as high-specific-activity labels in immunoassay.Clinical Chemistry, 1983
- Two-site assay of human α1-fetoprotein using125I-labelled monoclonal antibodiesBioscience Reports, 1981
- Automated two-site immunoradiometric assay of human alpha-fetoprotein in maternal serum.Clinical Chemistry, 1981
- SERUM-ALPHA1-FETOPROTEIN IN PATIENTS WITH TESTICULAR TUMOURSThe Lancet, 1976